HDFC MF and ADIA Lead ₹777 Crore Block Deal in Corona Remedies
A massive block deal unfolded in the pharmaceutical sector as major institutional players shook up the equity structure of Corona Remedies Limited. High-profile investors, including HDFC Mutual Fund and the Abu Dhabi Investment Authority (ADIA), stepped in to acquire significant stakes during this high-value transaction.
Details of the Massive Divestment
On June 17, 2026, a significant portion of the equity in Corona Remedies was offloaded through a coordinated block deal on the stock exchange. The primary seller, Sepia Investments, divested 43,28,943 shares at a price of ₹1,730 per share, amounting to approximately ₹748.9 crore.
Adding to the selling pressure, Anchor Partners also participated in the divestment, offloading 1,61,861 shares at the same price of ₹1,730 per share, worth roughly ₹28 crore. When combined, these two entities successfully exited positions worth a total of approximately ₹776.9 crore in the pharmaceutical company.
Institutional Heavyweights Drive the Buy Side
The transaction saw aggressive participation from twelve different institutional investors, signaling strong confidence in Corona Remedies' long-term prospects. HDFC Mutual Fund emerged as the dominant force on the buy side, acquiring 24,50,000 shares. This purchase, valued at roughly ₹423.9 crore, accounted for more than half of the total deal value.
Other prominent domestic and international players included:
- Aditya Birla Sun Life Mutual Fund: Purchased 4,90,000 shares worth ₹84.8 crore.
- Aberdeen Asian Smaller Companies Investment Trust Plc: Acquired 4,50,868 shares for approximately ₹78 crore.
- Invesco Mutual Fund: Picked up 2,89,017 shares worth about ₹50 crore.
- Kotak Mahindra Mutual Fund: Bought 1,61,861 shares, mirroring the exact quantity sold by Anchor Partners, in a deal worth ₹28 crore.
Global and Specialized Funds Join the Fold
The deal attracted significant interest from global sovereign wealth funds and emerging market specialists. The Abu Dhabi Investment Authority (ADIA) entered the fray by purchasing 39,130 shares valued at ₹6.8 crore.
Ekosistem WhiteOak dan dana-dana Aberdeen juga menunjukkan minat yang besar. Aberdeen Standard Sicav I - Asian Smaller Companies Fund menginvestasikan sekitar ₹47,4 crore, sementara WhiteOak Capital Mutual Fund dan Ashoka WhiteOak Emerging Markets Equity Fund masing-masing mengambil kepemilikan senilai ₹25,1 crore dan ₹25,7 crore. Partisipasi yang lebih kecil dilakukan oleh Factory Mutual Insurance Company dan TCW White Oak Emerging Markets Equity Fund, melengkapi kelompok penyedia modal yang sangat canggih dan beragam.
Poin-Poin Penting
- Keluar dalam Skala Besar: Sepia Investments dan Anchor Partners secara kolektif melepas saham senilai sekitar ₹776,9 crore di Corona Remedies.
- Dominasi HDFC MF: HDFC Mutual Fund adalah pembeli terbesar, menyerap lebih dari 50% dari total nilai transaksi dengan investasi sebesar ₹423,9 crore.
- Kepercayaan Institusional: Partisipasi raksasa global seperti ADIA serta berbagai dana Aberdeen dan WhiteOak menggarisbawahi minat institusional yang kuat terhadap perusahaan pada titik harga ₹1.730.